CLOV vs OVID · rev $1.37B vs rev $566.0K
Clover Health Investments Corp (CLOV) versus Ovid Therapeutics Inc (OVID) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported OVID revenue for 2024-12-31 was $566.0K. Net income was -$26.4M. Revenue was up 44.4% from 2023-12-31 to 2024-12-31. OVID currently screens at market cap $23.5M.
CLOV currently screens at market cap $1.55B. OVID currently screens at market cap $23.5M.
Not investment advice. Open the CLOV and OVID stock pages for the full models.
Not investment advice.